<DOC>
	<DOCNO>NCT00042029</DOCNO>
	<brief_summary>A clinical study determine efficacy safety MK0869 treatment depression .</brief_summary>
	<brief_title>Treatment Patients With Major Depressive Disorder With MK0869 ( 0869-073 )</brief_title>
	<detailed_description>The duration treatment 8 week .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<criteria>Patients Major Depressive Disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>